Yes, on one hand the blue sky potential of immunotherapies is all but gone. The main reason I chose to invest was because of AHZ's association with Prof Ian Frazer. That seemed like a good roll of the dice but unfortunately the lucky numbers didn't come up. Although that's not a fault of management. It's jus that theories didn't come to reality and that's part of the game.
On the other hand the rest of AHZ's business is growing and with good management we could have a nice little earner here. However, targets keep getting missed. Deadlines for breakeven sustainability keep getting pushed out. And capital raisings keep having to save the company. These are all management failures.
The reason this CR was different was because WP said he would do it again. He said that his reputation was on the line with that comment. How does anybody trust him after this? You can see the outrage that this has caused with myself and other posters on here. It seems like the market would agree with my view on this matter and not those that are critical of my view.
I'd personally like to see somebody else take the helm. I don't think that WP is able to realise AHZ's potential. One shouldn't put their reputation on the line, fail in their efforts and then expect to still have a reputation. And I don't want a reputation-less leader at the helm of the company.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)